This case demonstrates the utility of 18F-exendin-4 PET/CT, a novel GLP-1 receptor-targeted imaging technique, in accurately localizing an occult insulinoma even with negative findings of SACST, enabling minimally invasive curative surgery. The gene discussed is GLP1R; the disease is pancreatic insulinoma.